Dantrolene Sodium Capsule
Product Images NDC 50268-217

2 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dantrolene Sodium (NDC 50268-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dantrolene Sodium Capsules 1)

Chemical Structure (Dantrolene Sodium Capsules 1)
Chemical structure diagram of Dantrolene Sodium, showing its molecular components including a nitrophenyl group, a furan ring, an azo linkage, and a hydantoin ring with sodium and water of hydration (3 1/2 H2O).*
FDA Label Image

1 (217 15)

1 (217 15)
Dantrolene Sodium Capsules, USP 25 mg oral capsules with 50 capsules per unit dose (5 x 10). Label indicates it is a peripheral skeletal muscle relaxant, Rx only, manufactured for AvPAK in Pulaski, TN. The label displays the NDC 50268-217-15 and includes dosing and storage instructions along with a barcode and AvPAK logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.